CureMeAbroad Secures Pre-Seed Funding
AI-powered medical tourism platform CureMeAbroad has raised $600,000 in a pre-seed funding round to accelerate its growth and technology development.
The round saw participation from a group of prominent investors, including Roman Saini, Himanshu Ratnoo, Kunal Gupta, Devaiah Bopanna, and Vikrant Potnis, among others.
Addressing Gaps in Medical Tourism
Founded in June 2025 by Aditya Oza and Mikhail Bohra, the platform targets the cross-border medical travel segment, which remains fragmented and underdeveloped.
Key challenges in the sector include:
- Lack of pricing transparency
- Dependence on informal intermediaries
- Limited access to verified healthcare providers
- Gaps in post-treatment support
CureMeAbroad aims to solve these issues by creating a trusted discovery and decision-making platform for patients.
Building a Global Medical Discovery Platform
The startup’s AI-powered platform offers:
- Access to 6,000+ hospitals across 47 countries
- Coverage of 45 medical specialties
- Partnerships with over 380 accredited hospitals
Key medical travel destinations on the platform include:
- India
- Turkey
- Thailand
- Mexico
- Georgia
The platform is designed to simplify the process of selecting treatment options across geographies.
Leveraging AI for Better Decision-Making
CureMeAbroad is investing in advanced AI capabilities to enhance user experience and outcomes.
Key features under development include:
- AI-based cost estimation tools
- Clinical matching models for patients and providers
- Multilingual patient intelligence systems
These tools aim to improve transparency, accuracy, and accessibility in medical decision-making.
Large and Growing Market Opportunity
The global medical tourism market presents significant potential.
- Estimated market size: $174 billion by 2035
- Around 14 million patients travel abroad annually for treatment
Despite this scale, the lack of structured platforms creates an opportunity for technology-driven solutions.
Expansion Plans
The startup plans to use the fresh capital to:
- Strengthen its technology platform
- Expand its team
- Scale operations across key markets
Initial focus areas for expansion include:
- GCC countries
- United Kingdom
- African markets
These regions represent major source markets for medical tourism.
Founder Vision and Market Positioning
CureMeAbroad aims to position itself as a trusted global platform for medical travel, addressing a critical gap in the healthcare ecosystem.
The founders emphasize building a system where patients can make informed decisions without relying on unverified sources.
Future Fundraising Plans
The company is currently in discussions with institutional investors for its next funding round.
This upcoming seed round is expected to support further expansion and product development.
Final Thoughts
CureMeAbroad’s $600,000 funding round highlights the growing interest in AI-driven healthcare platforms, particularly in underserved segments like medical tourism.
By focusing on transparency, trust, and technology, the startup is addressing key challenges in cross-border healthcare.
If executed effectively, CureMeAbroad could play a significant role in organizing and scaling the global medical tourism ecosystem.
